Nephrology Practice Questions

Q: Which of the following is not a typical feature of haemolytic uremic syndrome?

Splenomegaly. ***Neuro psychiatric disturbances*** - Neuropsychiatric disturbances are not a direct feature of hemolytic uremic syndrome (HUS), which primarily affects renal and hematological systems. - HUS is characterized by a triad of **hemolytic anemia**, **thrombocytopenia**, and **acute renal failure**, without specific neuropsychiatric manifestations [2]. *Anaemia* - **Hemolytic anemia** is a key feature of HUS due to red blood cell destruction [1], [2]. - Patients often exhibit signs of **fatigue and pallor**, distinguishing it from other renal syndromes [3]. *Renal microthrombi* - HUS is characterized by the formation of **microthrombi in renal vasculature**, leading to acute kidney injury [1]. - The presence of these microthrombi is fundamental to the pathology of HUS [1]. *Hyperkalemia* - Renal failure in HUS can lead to **hyperkalemia** due to decreased potassium excretion. - It is a common complication associated with the acute renal failure seen in HUS.

Q: What is the initial treatment of choice for managing secondary hyperparathyroidism in patients with renal osteodystrophy?

Phosphate binders. ***Phosphate binders*** - **Phosphate binders** are the initial treatment because **hyperphosphatemia** is the primary driver of secondary hyperparathyroidism in renal disease, triggering parathyroid hormone (PTH) release [1]. - They work by binding dietary phosphate in the gastrointestinal tract, preventing its absorption and thus lowering serum phosphate levels [1]. *Cinacalcet* - **Cinacalcet** is a calcimimetic that increases the sensitivity of calcium-sensing receptors on the parathyroid gland, reducing **PTH secretion** [1]. - It is often used if **phosphate binders** and **vitamin D analogs** are insufficient in controlling PTH, making it a second-line treatment [1]. *Bisphosphonates* - **Bisphosphonates** are used to treat osteoporosis by inhibiting osteoclast activity and reducing bone resorption. - They are generally contraindicated in advanced renal osteodystrophy due to concerns about adynamic bone disease and are not an initial treatment for **secondary hyperparathyroidism**. *Calcium restriction* - While restricting dietary calcium might seem intuitive, **hypocalcemia** is often a problem in renal disease due to impaired vitamin D activation [1]. - Overly restricting calcium can worsen hypocalcemia, which would further stimulate PTH release, thus it is not an initial treatment for **secondary hyperparathyroidism**.

Q: Which of the following electrolyte imbalances is least likely to be observed in Chronic Renal Failure (CRF)?

Hypercalcemia. ***Hypercalcemia*** - In **chronic renal failure (CRF)**, the kidneys' inability to activate vitamin D leads to impaired calcium absorption and **hypocalcemia** [1], [2]. - Additionally, the kidneys fail to excrete phosphate, leading to **hyperphosphatemia**, which further exacerbates hypocalcemia by forming calcium-phosphate precipitates [1]. *Hyperkalemia* - **Hyperkalemia** is a common and serious complication of CRF due to the kidneys' impaired ability to excrete **potassium**. - This is exacerbated by conditions like **metabolic acidosis** and certain medications. *Hyperphosphatemia* - In CRF, the kidneys are unable to adequately excrete **phosphate**, leading to an accumulation of **phosphate** in the blood [1]. - This condition directly contributes to **secondary hyperparathyroidism** and bone disease [1], [2]. *Hypocalcemia* - **Hypocalcemia** is very common in CRF, primarily due to decreased production of **calcitriol (active vitamin D)** by the failing kidneys [2]. - Reduced calcitriol leads to lower intestinal **calcium absorption** and impaired bone mineralization [1].

Q: In which of the following conditions is hypomagnesemia not typically observed?

Diabetes mellitus. Diabetes mellitus - While hypomagnesemia can occur in poorly controlled diabetes due to osmotic diuresis, it is not a typical or defining feature of the condition itself in the same way as other options. - Many individuals with controlled diabetes may have normal magnesium levels, and it's often associated with complications rather than the primary disease process. Diarrhea - Chronic or severe diarrhea leads to significant gastrointestinal losses of electrolytes, including magnesium. - This is a common cause of hypomagnesemia, as the body loses fluids and minerals before they can be absorbed. Gitelman syndrome - This is a renal tubular disorder characterized by a defect in the thiazide-sensitive Na-Cl cotransporter in the distal convoluted tubule. - It leads to hypomagnesemia (due to increased renal excretion) and hypokalemia, along with metabolic alkalosis. Bartter syndrome - This syndrome involves a defect in the Na-K-2Cl cotransporter in the thick ascending limb of the loop of Henle. - It results in significant renal wasting of magnesium [1], leading to hypomagnesemia, along with hypokalemia and metabolic alkalosis.

Q: Distal renal tubular acidosis is associated with:

Calcium stones. ***Calcium stones*** - Distal renal tubular acidosis (Type 1 RTA) causes metabolic acidosis due to impaired distal tubular **hydrogen ion secretion**. - This leads to **increased urinary calcium excretion** (hypercalciuria) and decreased urinary citrate, creating an environment favorable for the formation of **calcium phosphate renal stones**. *Oxalate stones* - While oxalate is a component of some calcium stones (calcium oxalate), **primary hyperoxaluria** or dietary excess of oxalate are the main causes, not directly distal RTA. - Distal RTA specifically promotes **calcium phosphate stone formation** due to pH changes and hypercalciuria. *Hypocitraturia* - **Hypocitraturia** is indeed a feature of distal RTA as the kidney attempts to excrete acid by reabsorbing citrate, making the urine less inhibitory to stone formation. - However, the most direct and common clinically observed consequence in stone formation is the development of **calcium stones**, as hypocitraturia combined with hypercalciuria facilitates their formation. *Uric acid stones* - **Uric acid stones** typically form in persistently **acidic urine** and are associated with conditions like gout or myeloproliferative disorders. - While distal RTA results in systemic acidosis, the urine pH in distal RTA is typically **alkaline or inappropriately neutral**, which does not favor uric acid stone formation.

Q: What is the best treatment for anemia in patients with Chronic Renal Failure (CRF)?

Erythropoietin Stimulating Agents. ***Erythropoietin Stimulating Agents*** - **Erythropoietin Stimulating Agents (ESAs)** are the cornerstone of anemia treatment in CRF because the primary cause of anemia in these patients is inadequate production of **endogenous erythropoietin** by the damaged kidneys [1]. - ESAs stimulate the bone marrow to produce red blood cells, effectively reversing the anemia and improving symptoms like fatigue and exercise intolerance [1]. *Oral Iron Therapy* - While **iron deficiency** often coexists with **anemia of chronic disease** in CRF patients, oral iron alone is usually insufficient to correct the anemia; it only addresses the iron component. - Many CRF patients have **functional iron deficiency** due to chronic inflammation, which impairs iron utilization, making oral iron less effective even with adequate stores. *Blood transfusion* - **Blood transfusions** provide a rapid increase in hemoglobin but are not the preferred long-term treatment for anemia in CRF due to risks of **iron overload**, **alloreactions**, and potential sensitization, which can complicate future transplantation. - Transfusions are typically reserved for acute, severe anemia or specific circumstances where ESAs are ineffective or contraindicated. *Androgenic Steroids* - **Androgenic steroids** can stimulate erythropoiesis, but their use is limited due to significant side effects such as **hepatotoxicity**, **virilization**, and **cardiac complications**, making them a less favorable option compared to ESAs. - They are considered a secondary or tertiary option, often in patients unresponsive to primary treatments or when other options are exhausted.

Q: What is the most common presentation for IgA nephropathy?

Repeated gross hematuria. ***Repeated gross hematuria*** - The hallmark of **IgA nephropathy** is recurrent episodes of **gross hematuria**, particularly following **respiratory infections** [1]. - It is often associated with **renal impairment** but can present initially with **visible blood** in the urine [1]. *Nephritic syndrome* - While IgA nephropathy can lead to nephritic features, it does not commonly present primarily as **nephritic syndrome**, which includes hypertension and edema. - Nephritic syndrome is characterized by significant **proteinuria** and acute renal failure, rather than the classic presentation of hematuria [2]. *Microscopic hematuria* - Although **microscopic hematuria** can occur in IgA nephropathy, it is not the most common and noticeable presentation; **gross hematuria** is more characteristic [1]. - Microscopic hematuria lacks the acute visual symptoms seen in cases proving the diagnosis. *Nephritic syndrome* - This option is a repetition of and does not provide any additional unique characteristics specific to **IgA nephropathy**. - It shares the same clinical features discussed previously and is thus not representative of the most common presentation.

Q: Most common cause of nephrotic syndrome in adults?

Focal Segmental Glomerulosclerosis (FSGS). ***Membranous glomerulonephritis*** - Membranous glomerulonephritis is the **most common cause of nephrotic syndrome** in adults, often associated with **autoimmune diseases** or certain medications. [1] - Patients typically present with **heavy proteinuria**, edema, and a normal renal function in early stages. *Focal GN* - Focal glomerulosclerosis typically affects young individuals and may not usually present as nephrotic syndrome. - It is associated with **obesity** and **HIV**, often leading to more significant renal impairment compared to membranous glomerulonephritis. [1] *Acute GN* - Acute glomerulonephritis generally presents with **hematuria**, **hypertension**, and **renal failure**, rather than nephrotic syndrome. [1] - It can have different causes, such as infections or systemic diseases, but is not the primary condition leading to nephrotic syndrome in adults. *Minimal change disease* - Minimal change disease is more prevalent in **children** [1], and while it can occur in adults, it is less common as a cause of nephrotic syndrome in this demographic. - It is characterized by **responsive edema** to steroids, but its incidence is not as high as membranous glomerulonephritis in adults.

Q: Renal vein thrombosis is associated with all of the following conditions except:

Trauma. **Trauma** - While trauma to the abdomen can cause **renal injury** and other vascular issues, isolated **renal vein thrombosis** is not a common direct association or complication [1]. - Renal vein thrombosis typically results from conditions that lead to a **hypercoagulable state** or local vascular stasis. *Sickle cell anemia* - Individuals with **sickle cell anemia** are prone to **vaso-occlusive crises** from sickled red blood cells obstructing blood flow [2]. - This can lead to **renal medullary ischemia** and infarction, making them highly susceptible to **renal vein thrombosis**. *Nephrotic syndrome* - **Nephrotic syndrome** is a significant risk factor for **renal vein thrombosis** due to the urinary loss of **antithrombin III**, a natural anticoagulant. - This loss creates a **hypercoagulable state**, increasing the likelihood of thrombus formation in renal veins. *Dehydration* - Severe **dehydration** leads to **hemoconcentration** (increased blood viscosity) and reduced blood flow. - These factors promote a **hypercoagulable state**, increasing the risk of thrombotic events, including **renal vein thrombosis**, especially in vulnerable populations like infants or the elderly.

Q: In diabetic nephropathy, all of the following are true, except:

Insulin requirement becomes high. ***Insulin requirement becomes high*** - In advanced diabetic nephropathy, especially when renal function significantly declines, the **kidneys' ability to metabolize and excrete insulin decreases**. - This leads to a **prolonged half-life of insulin in the body**, often resulting in a *reduction* in required insulin doses as the disease progresses, rather than an increase. *Cardiovascular abnormalities can occur* - **Diabetic nephropathy** is a major risk factor for developing **cardiovascular disease**, including **hypertension**, atherosclerosis, and heart failure [3]. - The coexistence of these conditions accelerates disease progression and increases morbidity and mortality in diabetic patients [2]. *Micro and macro albuminuria can occur* - **Diabetic nephropathy** characteristically begins with **microalbuminuria** (small amounts of albumin in the urine), which is an early sign of kidney damage [1]. - As the disease progresses, it often advances to **macroalbuminuria** (larger amounts of albumin), indicating more severe kidney damage [1]. *ACE inhibitors can reduce micro albuminuria* - **Angiotensin-converting enzyme (ACE) inhibitors** are a cornerstone of treatment for diabetic nephropathy due to their **renoprotective effects**. - They effectively reduce **glomerular hydrostatic pressure** and **albuminuria**, thereby slowing the progression of kidney disease.

Question 1

Which of the following is not a typical feature of haemolytic uremic syndrome?

Accepted Answer

Splenomegaly

Answer

Anemia

Answer

Renal microthrombi

Answer

Hyperkalemia

Question 2

What is the initial treatment of choice for managing secondary hyperparathyroidism in patients with renal osteodystrophy?

Accepted Answer

Phosphate binders

Answer

Cinacalcet

Answer

Bisphosphonates

Answer

Calcium restriction

Question 3

Which of the following electrolyte imbalances is least likely to be observed in Chronic Renal Failure (CRF)?

Accepted Answer

Hypercalcemia

Answer

Hyperkalemia

Answer

Hyperphosphatemia

Answer

Hypocalcemia

Question 4

In which of the following conditions is hypomagnesemia not typically observed?

Accepted Answer

Diabetes mellitus

Answer

Diarrhea

Answer

Gitelman syndrome

Answer

Bartter syndrome

Question 5

Distal renal tubular acidosis is associated with:

Accepted Answer

Calcium stones

Answer

Hypocitraturia

Answer

Oxalate stones

Answer

Uric acid stones

Question 6

What is the best treatment for anemia in patients with Chronic Renal Failure (CRF)?

Accepted Answer

Erythropoietin Stimulating Agents

Answer

Oral Iron Therapy

Answer

Blood transfusion

Answer

Androgenic Steroids

Question 7

What is the most common presentation for IgA nephropathy?

Accepted Answer

Repeated gross hematuria

Answer

Nephritic syndrome

Answer

Nephrotic syndrome

Answer

Microscopic hematuria

Question 8

Most common cause of nephrotic syndrome in adults?

Accepted Answer

Focal Segmental Glomerulosclerosis (FSGS)

Answer

Minimal change disease

Answer

Acute GN

Answer

Membranous glomerulonephritis

Question 9

Renal vein thrombosis is associated with all of the following conditions except:

Accepted Answer

Trauma

Answer

Nephrotic syndrome

Answer

Dehydration

Answer

Sickle cell anemia

Question 10

In diabetic nephropathy, all of the following are true, except:

Accepted Answer

Insulin requirement becomes high

Answer

Micro and macro albuminuria can occur

Answer

ACE inhibitors can reduce micro albuminuria

Answer

Cardiovascular abnormalities can occur

Nephrology — MCQs

Nephrology — MCQs

On this page

Practice by Chapter

Want unlimited practice?